Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma

Abstract Here, we present two patients with bronchial asthma, who developed keratosis pilaris (KP) following treatment with dupilumab, a monoclonal antibody to IL‐4 receptor. Both of them reported pruritic papules in their extremities in 1 months after initiation of dupilumab therapy. The lesions ne...

Full description

Bibliographic Details
Main Authors: Yuka Shibata, Shigetoshi Sano
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Journal of Cutaneous Immunology and Allergy
Subjects:
Online Access:https://doi.org/10.1002/cia2.12172
_version_ 1797332332302041088
author Yuka Shibata
Shigetoshi Sano
author_facet Yuka Shibata
Shigetoshi Sano
author_sort Yuka Shibata
collection DOAJ
description Abstract Here, we present two patients with bronchial asthma, who developed keratosis pilaris (KP) following treatment with dupilumab, a monoclonal antibody to IL‐4 receptor. Both of them reported pruritic papules in their extremities in 1 months after initiation of dupilumab therapy. The lesions newly developed on the day of every administration of dupilumab at 2‐week interval, however, they tended to resolve over time until the next treatment. A diagnosis of KP was made from clinical and histopathologic findings. Dermoscopic examination revealed keratotic plugs with coiled, curly hairs. We suspected that dupilumab might abruptly impact on growth of vellus hair to generate KP.
first_indexed 2024-03-08T07:48:44Z
format Article
id doaj.art-4710040ae2894f3f9200982a22409a58
institution Directory Open Access Journal
issn 2574-4593
language English
last_indexed 2024-03-08T07:48:44Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Journal of Cutaneous Immunology and Allergy
spelling doaj.art-4710040ae2894f3f9200982a22409a582024-02-02T15:14:27ZengFrontiers Media S.A.Journal of Cutaneous Immunology and Allergy2574-45932021-08-0144828510.1002/cia2.12172Keratosis pilaris caused by dupilumab for the treatment of bronchial asthmaYuka Shibata0Shigetoshi Sano1Department of Dermatology Kochi Medical School Kochi University Nankoku JapanDepartment of Dermatology Kochi Medical School Kochi University Nankoku JapanAbstract Here, we present two patients with bronchial asthma, who developed keratosis pilaris (KP) following treatment with dupilumab, a monoclonal antibody to IL‐4 receptor. Both of them reported pruritic papules in their extremities in 1 months after initiation of dupilumab therapy. The lesions newly developed on the day of every administration of dupilumab at 2‐week interval, however, they tended to resolve over time until the next treatment. A diagnosis of KP was made from clinical and histopathologic findings. Dermoscopic examination revealed keratotic plugs with coiled, curly hairs. We suspected that dupilumab might abruptly impact on growth of vellus hair to generate KP.https://doi.org/10.1002/cia2.12172bronchial asthmacurly hairdupilumabhair folliclekeratosis pilarisTh2 pathway
spellingShingle Yuka Shibata
Shigetoshi Sano
Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
Journal of Cutaneous Immunology and Allergy
bronchial asthma
curly hair
dupilumab
hair follicle
keratosis pilaris
Th2 pathway
title Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
title_full Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
title_fullStr Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
title_full_unstemmed Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
title_short Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
title_sort keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
topic bronchial asthma
curly hair
dupilumab
hair follicle
keratosis pilaris
Th2 pathway
url https://doi.org/10.1002/cia2.12172
work_keys_str_mv AT yukashibata keratosispilariscausedbydupilumabforthetreatmentofbronchialasthma
AT shigetoshisano keratosispilariscausedbydupilumabforthetreatmentofbronchialasthma